These mechanisms include downregulation of NKG2D expression on effector cells, leading to T cell and NK cell dysfunction, and impaired NK cell self-renewal in tumor hosts, disrupting NK cell homeostasis [3,16,41]. The gene discussed is KLRK1; the disease is neoplasm.